Vitestro
Founded 2017 · 142 employees on LinkedIn · 2 known investors
Vitestro develops Aletta®, an autonomous blood collection (phlebotomy) device that uses automation and clinical validation to standardize blood draws. It targets hospitals and laboratories seeking to address phlebotomy staffing shortages and reduce preanalytical errors.
Investors · 2
Frequently asked questions
- What does Vitestro do?
- Vitestro develops Aletta®, an autonomous blood collection (phlebotomy) device that uses automation and clinical validation to standardize blood draws. It targets hospitals and laboratories seeking to address phlebotomy staffing shortages and reduce preanalytical errors.
- Who are Vitestro's investors?
- Vitestro's investors include NYBC Ventures, Sonder Capital.